(C) 2013 Elsevier GmbH All rights reserved “
“This paper is

(C) 2013 Elsevier GmbH. All rights reserved.”
“This paper is devoted to the equilibrium shapes of rotating liquid drops. Families of axisymmetric shapes are found using a perturbation technique for the governing nonlinear equation. Bifurcation and turning points are located by applying a special type of Hermite-Pade approximation. (C) 2013 Elsevier Inc. All rights reserved.”
“BACKGROUND:

Disparities in healthcare for the elderly are understudied, despite the increasing proportion of patients over 80 years of age. Advanced age is a principal risk factor for colorectal adenocarcinoma, but there are few data to guide treatment in the elderly patient population.\n\nMETHODS: We performed a retrospective review of prospectively gathered data on 10,433 patients diagnosed with primary colon tumors between 1998 and 2004. We compared demographics, stage at diagnosis, and initial treatment between Autophagy inhibitor price patients Younger than 80 years and

those age 80 years or older.\n\nRESULTS: Patients who were >= 80 years old DNA-PK inhibitor made up 30% of the database. Older patients were less likely to have colectomy for advanced or metastatic disease than younger patients. Patients who were >= 80 years of age had fewer lymph nodes removed than younger patients (11 vs 10, P <.01). Older patients were significantly less likely to receive chemotherapy for every stage of colon cancer than younger patients. When older patients did get chemotherapy, it was more likely to be with a single agent. Multivariate analysis revealed that predictors of receiving chemotherapy for patients >= 80 years of age include living in an urban county, younger age, and worse stage at diagnosis.\n\nCONCLUSIONS: Older patients make up a large portion of the patients treated for colon cancer

and are treated less aggressively. While some of the treatment difference may be explained by medical factors, demographic factors affect treatment decisions as well. (C) 2009 Elsevier Inc. All rights reserved.”
“In pregnant rats, a significant decrease in myometrial relaxin family peptide receptor 1 (RXFP1) expression, indicative of a functional relaxin withdrawal for activation of myometrial contractions, occurs in late gestation and during spontaneous labor. This coincides with DZNeP the highest level of circulating relaxin and a decrease in progesterone. We investigated the potential regulatory role of these two systemic factors on myometrial RXFP1 expression by examining the effects of the antiprogestin RU486 and a monoclonal antibody against rat relaxin (MCA1) in pregnant rats. Rats were injected with RU486 on Gestational Day (GD) 7, 16, or 19 and were killed on GD 8, 17, or 20. RU486 caused a significant reduction in myometrial RXFP1. Plasma progesterone and 17beta-estradiol levels were increased in RU486-treated animals compared with controls.

Comments are closed.